Delivery Order SPE2DB20D2104-SPE2DB24FS26U
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of pharmaceutical products, including Myrbetriq ER 25 mg tablets, to support military healthcare programs. The contract has a ceiling value of $78,661.55 and a completion date of August 13, 2021. This is a firm fixed-price delivery order contract, and there is no set-aside designation...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,059.84 firm-fixed-price delivery order is for the drug Myrbetriq ER 25 mg tablets and has a completion date of September 7, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Myrbetriq ER 25 mg tablets to be provided by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,055.01 Firm Fixed Price contract has a completion date of March 2, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,157.20 firm fixed-price delivery order is for the pharmaceutical product Myrbetriq ER 50 MG Tablet 90s. The contract has an ultimate completion date of December 28, 2023. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,644.73 firm fixed-price delivery order is for Myrbetriq ER 50 mg tablets and has a completion date of June 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,885.50 firm fixed-price delivery order is for the supply of Myrbetriq ER 25 mg tablets and has an ultimate completion date of July 28, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA) under a firm-fixed price delivery order. The $16,594.29 contract, awarded on April 12, 2022, has an ultimate completion date of April 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,120.91 firm fixed-price delivery order is for the medication Myrbetriq ER 50 mg tablet, with an ultimate completion date of October 29, 2021. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Myrbetriq ER 25 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $5,503.28 and an ultimate completion date of May 31, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The $1,888.17 Firm Fixed Price delivery order covers the supply of Myrbetriq ER 50 mg tablets for the DLA Troop Support Medical and was awarded on September 17, 2021 with a completion date of September 20, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS26UDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,953.88 firm fixed-price delivery order is for the pharmaceutical product Myrbetriq ER 25 mg Tablet 90s. The award has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, with a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 1/26/24 |